In another hiPSC-CMs model of CPVT1 (RyR2-G2311A), the CamKII inhibitor KN-93 abolished isoprotenerol-induced DADs, thereby rescuing the arrhythmogenic phenotype [117]. Here, RYR2 is linked to catecholaminergic polymorphic ventricular tachycardia 1.